Kostoglou-Athanassiou, I., Athanassiou, P., Lyraki, A., Raftakis, I., & Antoniadis, C
Biotechnology & Biotechnological Equipment, 29(2), 205220
Mistake #4: Not Rotating Injection Sites The issue: Using the same syringe configuration at the same site repeatedly causes lipohypertrophy (fatty lumps under skin)
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
Doctors must consider the pros and cons of each option and work with patients to find the best plan
Zepbound is approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity